FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “NewLeaf Brands Wholly Owned Subsidiary We Are Kured, LLC Announces 100% Plant Based CBD Oil Formulation with Zero MCT, VG, Vitamin E or Other Cutting Agents.”
NewLeaf Brands Inc.’s (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) wholly owned subsidiary We Are Kured, LLC (“Kured”) is pleased to announce its new CBD oil formulation, which contains high-end CBD distillate, flavorless hemp derived terpenes and flavored terpenes in Pineapple Express, Strawberry Diesel and OG Kush.
NewLeaf Brands, Inc. is an innovative Cannabidiol lifestyle Company. Through the Company’s wholly-owned subsidiaries We are Kured, LLC, Drink Fresh Water, LLC, ReLyfe Brand, LLC and TeaLief Brand, LLC the Company’s main business activities encompass the development, marketing, and distribution of CBD products (including vaporizer pens/cartridges, hot/cold tea, softgel capsules and beverages) throughout North America, South America, and Europe. In addition, NewLeaf Brands, Inc. has extensive retail and cultivation land investments in Oregon, USA.
Over a dozen countries have legalized cannabis for medicinal purposes while others have decriminalized it, allowing for moderate personal consumption. Overall, as consumption spreads, communities become more aware of the various strains of the cannabis plant and the differences between them. Hemp, for example, is most commonly known as the derivative of the cannabis plant, and is one of the two main components found within the cannabis family. Compared to its counterpart, marijuana, the two are widely different in their biological makeup. Specifically, hemp’s main active ingredient is CBD or cannabidiol, while marijuana’s main compound is THC or tetrahydrocannabinol. THC is known to cause cerebral-altering effects on consumers, which is why marijuana is highly potent and illegal in most regions around the world. On the other hand, the hemp plant contains very minimal traces of THC, and an abundance of CBD. Generally, hemp contains less than 0.3% levels of THC, which is not enough to cause psychoactive effects. Nonetheless, CBD does provide therapeutic benefits, which many medical institutions have begun to leverage. Researchers have conducted thousands of studies to understand the efficacy of CBD, however, most studies are on a small-scale. As such, the U.S. Food and Drug Administration has explicitly noted that clinical trials must have over thousands of test subjects and deliver overwhelming positive results in order for CBD to be approved. Eventually, the FDA did pass Epidiolex, which is a CBD-based drug used to treat epilepsy. Moreover, other nations have approved the use of CBD to treat chronic conditions such as HIV/AIDS and multiple sclerosis. And now. the growing adoption of hemp-derived CBD products is ultimately driving the overall hemp industry as it continues to outpace the other segments. According to data compiled by Hemp Business Journal, a division of New Frontier Data, the total sales for the U.S. hemp industry totaled USD 820 Million in 2017. The research suggests that the industry is expected to grow to USD 1.9 Billion by 2022 and at a CAGR of 14.4% during the 5-year period.
The U.S. is primarily limited to the CBD industry since other aspects of the cannabis plant are still federally illegal. On the other hand, Canada has zero restrictions because it completely legalized cannabis in late 2018, joining Uruguay as the only two nations in the world to do so. Notably, during the first day of legalization, many dispensaries and online platforms experienced shortages throughout the country due to the massive amount of consumers looking to purchase cannabis products. In efforts to provide consumers with convenience and comfort, some businesses even launched delivery options where consumers can order online and then have cannabis products delivered right to their doors. Moving forward, industry experts believe that cannabis will continue to be integrated into mainstream retail as the next waves of legalization take hold. For instance, Canada’s second legalization, which is expected to occur in late 2019, is focused on edibles and beverages. Furthermore, the third wave of legalization is primarily expected to be focused on a variety of products such as shampoos, lotions, and other skincare products. In particular, the third wave is expected to be heavily integrated into mainstream retail operations. “When you think about it, cannabis and e-commerce are a match made in heaven. If you’re at home and looking to pick up some cannabis or cannabis-derived products, would you want to get dressed, trudge down the store, wait in line, and potentially have to talk to strangers to place an order? Or would you rather get your cannabis at the click of a button?” said Joresa Blount, Content Marketing Strategist at Early Growth Financial Services and former writer at Forbes. “As e-commerce continues to redefine retail, convenience will be the determining factor in cannabis consumer preferences.”
For more information, please visit: NewLeaf Brands, Inc.
For more corporate news on NewLeaf Brands, Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.